John Salsman to Carcinoma, Renal Cell
This is a "connection" page, showing publications John Salsman has written about Carcinoma, Renal Cell.
Connection Strength
0.119
-
Beaumont JL, Salsman JM, Diaz J, Deen KC, McCann L, Powles T, Hackshaw MD, Motzer RJ, Cella D. Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma. Cancer. 2016 Apr 01; 122(7):1108-15.
Score: 0.119